Boston, MA, United States of America

Normoxys, Inc.


USPTO Granted Patents = 6

% Expired Patents = 100.0


Forward Citations = 24

Loading Chart...
Loading Chart...

4 inventors (with patents filed for the assignee):

goldMedal Yves Claude Nicolau (6 out of 13 patents)

silverMedal Ruth Greferath (6 out of 12 patents)

bronzeMedal Jean-Marie Lehn (6 out of 29 patents)

4.  Konstantina C Fylaktakidou (6 out of 7 patents)

5.  Claudine Kieda (5 patents)

6.  Claude Nicolau (5 patents)

7.  Jean Marie Lehn (0 patent)


6 patents:

Company Overview
Normoxys, Inc. is a biotechnology company focused on developing innovative solutions for oxygen therapy. Our mission is to improve the lives of patients by providing cutting-edge technologies to ensure proper oxygenation. With a team of experienced scientists and engineers, we are dedicated to creating advanced products that address the challenges of oxygen therapy in various clinical settings. Our ultimate goal is to revolutionize the way oxygen is delivered and administered, leading to better patient outcomes and quality of life.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#268 in Boston, MA

#2,546 in Massachusetts

#45,007 in US

Boston, MA (US)
Boston, MA, United States of America
Forward Citations = 24

4 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Normoxys, Inc.. Retrieved from https://idiyas.com/company/normoxys

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…